USD 18.04
↓ -2.96 (-14.1%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| PHR | -14.1 | -14.6 | -14.2 | -25.9 | -24.5 | 12.9 | -75.1 | -39.0 | -28.1 | -28.1 |
| S&P 500 | -1.3 | -1.8 | 1.0 | 5.9 | 10.6 | 30.4 | 25.4 | 88.1 | 187.6 | 33142.5 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | PHR |
| name | Phreesia, Inc. |
| price | 18.04 |
| changes percentage | -14.0952 |
| change | -2.96 |
| day low | 17.07 |
| day high | 20.91 |
| year high | 29.155 |
| year low | 14.545 |
| market cap | 1042230332 |
| price avg 50 | 21.3956 |
| price avg 200 | 22.71005 |
| exchange | NYSE |
| volume | 1022045 |
| avg volume | 383210 |
| open | 20.91 |
| previous close | 21 |
| eps | -1.67 |
| pe | -10.8 |
| earnings announcement | 2024-12-09T21:03:00.000+0000 |
| shares outstanding | 57773300 |
| timestamp | 2024-11-15 21:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001412408 | |||
| revenue | 356299000 | 280910000 | 26.84 |
| gross profit | 201745000 | 171643000 | 17.54 |
| gross profit ratio | 0.57 | 0.61 | -7.33 |
| research and development expenses | 112346000 | 91244000 | 23.13 |
| operating expenses | 335118000 | 348195000 | -3.76 |
| interest income | 4065000 | 2475000 | 64.24 |
| interest expense | 1854000 | 1411000 | 31.40 |
| ebitda | -102945000 | -145484000 | 29.24 |
| ebitdaratio | -0.29 | -0.54 | 46.34 |
| operating income | -131773000 | -176552000 | 25.36 |
| operating income ratio | -0.37 | -0.63 | 41.16 |
| net income | -136885000 | -176146000 | 22.29 |
| net income ratio | -0.38 | -0.63 | 38.73 |
| eps | -2.51 | -3.36 | 25.30 |
Revenue Growth: revenue increased to 356 million in 2024 from 281 million in 2023 representing a change of 26.84%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 202 million in 2024 from 172 million in 2023 representing a change of 17.54%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 335 million in 2024 from 348 million in 2023 representing a change of -3.76%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
Earnings per Share (EPS): EPS increased to -2.51 in 2024 from -2.51 in 2023 representing a change of 25.3%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Research and Development (R&D) Expenses: R&D Expenses decreased to 112 million in 2024 from 91 million in 2023 representing a change of 23.13%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -103 million in 2024 from -145 million in 2023 representing a change of 29.24%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to -132 million in 2024 from -177 million in 2023 representing a change of 25.36%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to -137 million in 2024 from -176 million in 2023 representing a change of 22.29%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0001412408 | |||
| revenue | 102115000 | 101217000 | 0.89 |
| gross profit | 61809000 | 60332000 | 2.45 |
| gross profit ratio | 0.61 | 0.6 | 1.55 |
| research and development expenses | 29542000 | 28881000 | 2.29 |
| operating expenses | 79031000 | 79752000 | -0.90 |
| interest income | 654000 | 792000 | -17.42 |
| interest expense | 608000 | 553000 | 9.95 |
| ebitda | -9159000 | -11794000 | 22.34 |
| ebitdaratio | -0.09 | -0.12 | 27.69 |
| operating income | -17222000 | -19420000 | 11.32 |
| operating income ratio | -0.17 | -0.19 | 12.10 |
| net income | -18012000 | -19722000 | 8.67 |
| net income ratio | -0.18 | -0.19 | 9.47 |
| eps | -0.31 | -0.35 | 11.43 |
Revenue Growth: revenue increased to 102 million in 2025Q2 from 101 million in 2025Q1 representing a change of 0.89%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 62 million in 2025Q2 from 60 million in 2025Q1 representing a change of 2.45%. This indicates a sales profitability growth, which is a positive sign for the company.
Research and Development (R&D) Expenses: R&D Expenses increased to 30 million in 2025Q2 from 29 million in 2025Q1 representing a change of 2.29%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.
Operating Expenses: Operating Expenses decreased to 79 million in 2025Q2 from 80 million in 2025Q1 representing a change of -0.9%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -9 million in 2025Q2 from -12 million in 2025Q1 representing a change of 22.34%. The increase in EBITDA indicates improved operational efficiency and profitability.
Earnings per Share (EPS): EPS increased to -0.31 in 2025Q2 from -0.31 in 2025Q1 representing a change of 11.43%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Operating Income: Operating income decreased to -17 million in 2025Q2 from -19 million in 2025Q1 representing a change of 11.32%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to -18 million in 2025Q2 from -20 million in 2025Q1 representing a change of 8.67%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001412408 | |||
| total assets | 370326000 | 370057000 | 0.07 |
| total liabilities | 118877000 | 82238000 | 44.55 |
| total equity | 251449000 | 287819000 | -12.64 |
| cash and cash equivalents | 87520000 | 176683000 | -50.46 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 0 | NaN |
| total current assets | 195684000 | 262441000 | -25.44 |
| total non current assets | 174642000 | 107616000 | 62.28 |
| total current liabilities | 110119000 | 79039000 | 39.32 |
| total non current liabilities | 8758000 | 3199000 | 173.77 |
| common stock | 577000 | 542000 | 6.46 |
| retained earnings | -742969000 | -606084000 | -22.59 |
| total debt | 11983000 | 9180000 | 30.53 |
Total Assets: Total Assets increased to 370 million in 2024 from 370 million in 2023 representing a change of 0.07%. Suggesting a growth in asset holdings.
Common Stock: Common Stock increased to 1 in 2024 from 1 in 2023 representing a change of 6.46%. This indicates an increase in ownership interest.
Total Liabilities: Total Liabilities increased to 119 million in 2024 from 82 million in 2023 representing a change of 44.55%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 251 million in 2024 from 288 million in 2023 representing a change of -12.64%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 88 million in 2024 from 177 million in 2023 representing a change of -50.46%. This indicates a decrease in available liquid assets.
Total Current Assets: Total Current Assets decreased to 196 million in 2024 from 262 million in 2023 representing a change of -25.44%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 110 million in 2024 from 79 million in 2023 representing a change of 39.32%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -743 million in 2024 from -606 million in 2023 representing a change of -22.59%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 12 million in 2024 from 9 million in 2023 representing a change of 30.53%. This indicates an increase in overall debt burden.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0001412408 | |||
| total assets | 362235000 | 372086000 | -2.65 |
| total liabilities | 110900000 | 119344000 | -7.08 |
| total equity | 251335000 | 252742000 | -0.56 |
| cash and cash equivalents | 81798000 | 79527000 | 2.86 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 0 | NaN |
| total current assets | 180928000 | 190133000 | -4.84 |
| total non current assets | 182148000 | 181953000 | 0.11 |
| total current liabilities | 101999000 | 108282000 | -5.80 |
| total non current liabilities | 8901000 | 11061999 | -19.54 |
| common stock | 591000 | 587000 | 0.68 |
| retained earnings | -780703000 | -762691000 | -2.36 |
| total debt | 16522000 | 17505000 | -5.62 |
Total Assets: Total Assets decreased to 362 million in 2025Q2 from 372 million in 2025Q1 representing a change of -2.65%. Suggesting a decrease in asset holdings.
Total Equity: Total Equity decreased to 251 million in 2025Q2 from 253 million in 2025Q1 representing a change of -0.56%. This indicates a decrease in shareholders' equity.
Total Current Assets: Total Current Assets decreased to 181 million in 2025Q2 from 190 million in 2025Q1 representing a change of -4.84%. This indicates a worsen liquidity position.
Retained Earnings: Retained Earnings decreased to -781 million in 2025Q2 from -763 million in 2025Q1 representing a change of -2.36%. This indicates an accumulated losses.
Total Liabilities: Total Liabilities decreased to 111 million in 2025Q2 from 119 million in 2025Q1 representing a change of -7.08%. This indicates a decrease in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 82 million in 2025Q2 from 80 million in 2025Q1 representing a change of 2.86%. This indicates an increase in available liquid assets.
Total Current Liabilities: Total Current Liabilities decreased to 102 million in 2025Q2 from 108 million in 2025Q1 representing a change of -5.8%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 1 in 2025Q2 from 1 in 2025Q1 representing a change of 0.68%. This indicates an increase in ownership interest.
Total Debt: Total Debt decreased to 17 million in 2025Q2 from 18 million in 2025Q1 representing a change of -5.62%. This indicates a reduction in overall debt burden.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001412408 | |||
| net change in cash | -89163000 | -137129000 | 34.98 |
| operating cash flow | -32378000 | -90123000 | 64.07 |
| free cash flow | -57475000 | -116326000 | 50.59 |
| capital expenditure | -25097000 | -26203000 | 4.22 |
| depreciation and amortization | 29487000 | 25304000 | 16.53 |
| deferred income tax | 228000 | 434000 | -47.47 |
| stock based compensation | 71613000 | 58775000 | 21.84 |
| accounts payables | -1993000 | 4774000 | -141.75 |
| inventory | 0 | 0 | NaN |
| acquisitions net | -14573000 | 0 | NaN |
| investments in property plant and equipment | -5806000 | -26203000 | 77.84 |
| net cash used for investing activites | -39670000 | -26203000 | -51.39 |
| debt repayment | -6779000 | -5731000 | -18.29 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -12176000 | -19383000 | 37.18 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -17115000 | -20406000 | 16.13 |
| cash at end of period | 87520000 | 176683000 | -50.46 |
| accounts receivables | -11205000 | -11132000 | -0.66 |
| cash at beginning of period | 176683000 | 313812000 | -43.70 |
Net Change in Cash: Net Change in Cash increased to -89 million in 2024 from -137 million in 2023 representing a change of 34.98%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to -32 million in 2024 from -90 million in 2023 representing a change of 64.07%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to -57 million in 2024 from -116 million in 2023 representing a change of 50.59%. This indicates an increase in cash generated after accounting for capital expenditures.
Accounts Payables: The absolute value of Accounts Payables decreased to 2 million in 2024 from 5 million in 2023 representing a change of -141.75%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to -11 million in 2024 from -11 million in 2023 representing a change of -0.66%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Capital Expenditure: Capital Expenditure increased to -25 million in 2024 from -26 million in 2023 representing a change of 4.22%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation increased to 72 million in 2024 from 59 million in 2023 representing a change of 21.84%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0001412408 | |||
| operating cash flow | 11061000 | -873000 | 1367.01 |
| free cash flow | 3658000 | -6319000 | 157.89 |
| capital expenditure | -7403000 | -5446000 | -35.93 |
| depreciation and amortization | 7303000 | 6865000 | 6.38 |
| deferred income tax | 56000 | 63000 | -11.11 |
| stock based compensation | 16448000 | 16840000 | -2.33 |
| accounts receivables | 4976000 | -1393000 | 457.21 |
| accounts payables | 1186000 | -2936000 | 140.40 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -4427000 | -5446000 | 18.71 |
| net cash used for investing activites | -7403000 | -5446000 | -35.93 |
| debt repayment | -1995000 | -1280000 | -55.86 |
| common stock issued | 909000 | 1260000 | -27.86 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -1381000 | -1673000 | 17.45 |
| net change in cash | 2271000 | -7993000 | 128.41 |
| cash at end of period | 81798000 | 79527000 | 2.86 |
| cash at beginning of period | 79527000 | 87520000 | -9.13 |
Net Change in Cash: Net Change in Cash increased to 2 million in 2025Q2 from -8 million in 2025Q1 representing a change of 128.41%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 11 million in 2025Q2 from -1 million in 2025Q1 representing a change of 1367.01%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 4 million in 2025Q2 from -6 million in 2025Q1 representing a change of 157.89%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -7 million in 2025Q2 from -5 million in 2025Q1 representing a change of -35.93%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 16 million in 2025Q2 from 17 million in 2025Q1 representing a change of -2.33%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2025Q2 from 3 million in 2025Q1 representing a change of 140.4%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 5 in 2025Q2 from -1 million in 2025Q1 representing a change of 457.21%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q2 2025 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2024-01-31 | 2023-01-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2024 | 2023 | NaN |
| revenue per share | 6.53 | 5.36 | 21.91 |
| net income per share | -2.51 | -3.36 | 25.31 |
| operating cash flow per share | -0.59 | -1.72 | 65.47 |
| free cash flow per share | -1.05 | -2.22 | 52.51 |
| cash per share | 1.6 | 3.37 | -52.39 |
| book value per share | 4.61 | 5.49 | -16.03 |
| tangible book value per share | 1.79 | 3.96 | -54.69 |
| shareholders equity per share | 4.61 | 5.49 | -16.03 |
| interest debt per share | 0.09 | 0.09 | 1.60 |
| market cap | 1390225720.52 | 1965978111.83 | -29.29 |
| enterprise value | 1314688720.52 | 1798475111.83 | -26.90 |
| pe ratio | -10.16 | -11.16 | 9.00 |
| price to sales ratio | 3.9 | 7.0 | -44.25 |
| pocfratio | -42.94 | -21.81 | -96.83 |
| pfcf ratio | -24.19 | -16.9 | -43.12 |
| pb ratio | 5.53 | 6.83 | -19.06 |
| ptb ratio | 5.53 | 6.83 | -19.06 |
| ev to sales | 3.69 | 6.4 | -42.37 |
| enterprise value over ebitda | -12.77 | -12.36 | -3.31 |
| ev to operating cash flow | -40.6 | -19.96 | -103.47 |
| ev to free cash flow | -22.87 | -15.46 | -47.95 |
| earnings yield | -0.1 | -0.09 | -9.89 |
| free cash flow yield | -0.04 | -0.06 | 30.13 |
| debt to equity | 0.01 | 0.01 | 8.50 |
| debt to assets | 0.01 | 0.01 | -5.28 |
| net debt to ebitda | 0.73 | 1.15 | -36.27 |
| current ratio | 1.78 | 3.32 | -46.48 |
| interest coverage | -71.07 | -125.13 | 43.20 |
| income quality | 0.24 | 0.51 | -53.77 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.22 | 0.29 | -21.61 |
| research and ddevelopement to revenue | 0.32 | 0.32 | -2.93 |
| intangibles to total assets | 0.41 | 0.22 | 91.19 |
| capex to operating cash flow | -0.78 | -0.29 | -166.60 |
| capex to revenue | 0.07 | 0.09 | -24.49 |
| capex to depreciation | 0.85 | 1.04 | -17.81 |
| stock based compensation to revenue | 0.2 | 0.21 | -3.94 |
| graham number | 16.13 | 20.37 | -20.81 |
| roic | -0.52 | -0.61 | 13.91 |
| return on tangible assets | -0.63 | -0.61 | -3.91 |
| graham net net | 0.32 | 2.55 | -87.28 |
| working capital | 85565000 | 183402000 | -53.35 |
| tangible asset value | 97840000 | 207532000 | -52.86 |
| net current asset value | 76807000 | 180203000 | -57.38 |
| invested capital | 256342000 | 285928000 | -10.35 |
| average receivables | 58128500 | 45828000 | 26.84 |
| average payables | 9658000 | 7977500 | 21.07 |
| average inventory | 912000 | 1349000 | -32.39 |
| days sales outstanding | 66.45 | 66.78 | -0.50 |
| days payables outstanding | 20.03 | 36.2 | -44.67 |
| days of inventory on hand | 1.81 | 3.53 | -48.58 |
| receivables turnover | 5.49 | 5.47 | 0.50 |
| payables turnover | 18.23 | 10.08 | 80.74 |
| inventory turnover | 201.24 | 103.47 | 94.49 |
| roe | -0.54 | -0.61 | 11.05 |
| capex per share | 0.46 | 0.5 | -7.94 |
ROE: Return on Equity (ROE) increased to -0.54 on 2024-01-31 from -0.61 on 2023-01-31, representing a change of 11.05%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -10.16 on 2024-01-31 from -11.16 on 2023-01-31, representing a change of 9.00%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2024-01-31 from 0.01 on 2023-01-31, representing a change of 8.50%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Current Ratio: Current Ratio decreased to 1.78 on 2024-01-31 from 3.32 on 2023-01-31, representing a change of -46.48%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
| 2024-07-31 Q2 | 2024-04-30 Q1 | Q/Q change % | |
|---|---|---|---|
| PHR | |||
| calendar year | 2025 | 2025 | NaN |
| revenue per share | 1.78 | 1.79 | -0.58 |
| net income per share | -0.31 | -0.35 | 10.00 |
| operating cash flow per share | 0.19 | -0.02 | 1348.58 |
| free cash flow per share | 0.06 | -0.11 | 157.05 |
| cash per share | 1.42 | 1.4 | 1.36 |
| book value per share | 4.37 | 4.46 | -2.00 |
| tangible book value per share | 1.67 | 1.73 | -3.52 |
| shareholders equity per share | 4.37 | 4.46 | -2.00 |
| interest debt per share | 0.05 | 0.05 | 0.63 |
| market cap | 1434698827.05 | 1175259290.14 | 22.08 |
| enterprise value | 1369422827.05 | 1113237290.14 | 23.01 |
| pe ratio | -19.91 | -14.9 | -33.66 |
| price to sales ratio | 14.05 | 11.61 | 21.00 |
| pocfratio | 129.71 | -1346.23 | 109.63 |
| pfcf ratio | 392.21 | -185.99 | 310.88 |
| pb ratio | 5.71 | 4.65 | 22.76 |
| ptb ratio | 5.71 | 4.65 | 22.76 |
| ev to sales | 13.41 | 11.0 | 21.93 |
| enterprise value over ebitda | -149.52 | -94.39 | -58.40 |
| ev to operating cash flow | 123.81 | -1275.19 | 109.71 |
| ev to free cash flow | 374.36 | -176.17 | 312.50 |
| earnings yield | -0.01 | -0.02 | 25.19 |
| free cash flow yield | 0.0 | -0.01 | 147.42 |
| debt to equity | 0.01 | 0.01 | 0.56 |
| debt to assets | 0.01 | 0.01 | 2.72 |
| net debt to ebitda | 7.13 | 5.26 | 35.53 |
| current ratio | 1.77 | 1.76 | 1.02 |
| interest coverage | -28.33 | -35.12 | 19.34 |
| income quality | -0.61 | 0.04 | -1487.30 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.19 | 0.19 | 1.44 |
| research and ddevelopement to revenue | 0.29 | 0.29 | 1.39 |
| intangibles to total assets | 0.43 | 0.42 | 3.15 |
| capex to operating cash flow | 0.67 | -6.24 | 110.73 |
| capex to revenue | 0.07 | 0.05 | 34.74 |
| capex to depreciation | 1.01 | 0.79 | 27.78 |
| stock based compensation to revenue | 0.16 | 0.17 | -3.19 |
| graham number | 5.55 | 5.91 | -6.09 |
| roic | -0.07 | -0.08 | 9.36 |
| return on tangible assets | -0.09 | -0.09 | 4.03 |
| graham net net | 0.3 | 0.17 | 72.39 |
| working capital | 78929000 | 81851000 | -3.57 |
| tangible asset value | 95839000 | 97895000 | -2.10 |
| net current asset value | 70028000 | 70789000 | -1.08 |
| invested capital | 257243000 | 259667000 | -0.93 |
| average receivables | 63764499.5 | 65558999.5 | -2.74 |
| average payables | 6830000 | 7582000 | -9.92 |
| average inventory | 420500.5 | 0.5 | 84100000.00 |
| days sales outstanding | 54.0 | 58.91 | -8.33 |
| days payables outstanding | 15.58 | 14.71 | 5.87 |
| days of inventory on hand | 1.88 | 0.0 | 85308005.49 |
| receivables turnover | 1.67 | 1.53 | 9.09 |
| payables turnover | 5.78 | 6.12 | -5.54 |
| inventory turnover | 47.93 | 40885000 | -100.00 |
| roe | -0.07 | -0.08 | 8.16 |
| capex per share | 0.13 | 0.1 | 33.96 |
ROE: Return on Equity (ROE) increased to -0.07 on 2024-07-31 Q2 from -0.08 on 2024-04-30 Q1, representing a change of 8.16%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -19.91 on 2024-07-31 Q2 from -14.90 on 2024-04-30 Q1, representing a change of -33.66%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.77 on 2024-07-31 Q2 from 1.76 on 2024-04-30 Q1, representing a change of 1.02%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2024-07-31 Q2 from 0.01 on 2024-04-30 Q1, representing a change of 0.56%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-07 05:31:08
Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Sentiment: Neutral
Publish Date: 2024-11-01 06:48:00
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024.
Sentiment: Positive
Publish Date: 2024-10-28 06:48:00
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform.
Sentiment: Positive
Publish Date: 2024-10-10 10:35:21
Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Sentiment: Positive
Publish Date: 2024-10-08 06:48:00
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has joined the NAI to shape the national conversation around data privacy and promote consumer choice and transparency.
Sentiment: Positive
Publish Date: 2024-10-03 06:48:00
ALL-REMOTE COMPANY/WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia has collaborated with the Ad Council to bring three public health campaigns about mental health directly to patients and caregivers.
Sentiment: Positive
Publish Date: 2024-10-01 06:48:00
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that its contract with the CMS Innovation Center for use of the Patient Activation Measure® has been renewed to 2029.
Sentiment: Positive
Publish Date: 2024-09-05 12:19:59
I maintain a buy rating for PHR, driven by strong client growth, solid revenue outlook, and increasing transaction sizes in the pipeline. PHR's 2Q25 results show 19% y/y revenue growth and improved profitability, with positive EBITDA and FCF, indicating strong financial health. Despite a slight decline in revenue per AHSC, larger client acquisitions and increased transaction sizes support my 20% growth expectation.
Sentiment: Positive
Publish Date: 2024-09-04 20:08:07
Phreesia, Inc. (NYSE:PHR ) Q2 2025 Earnings Conference Call September 4, 2024 5:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Scott Schoenhaus - KeyBanc Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Glen Santangelo - Jefferies Stephanie Davis - Barclays Joe Vruwink - Baird John Ransom - Raymond James Richard Close - Canaccord Security Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Jeff Garro - Stephens Matthew Shea - Needham & Company Jack Wallace - Guggenheim Aaron Kimson - Citizens JMP Operator Good evening, ladies and gentlemen, and welcome to the Phreesia Second Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in a listen-only mode.
Sentiment: Positive
Publish Date: 2024-09-04 19:01:06
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sentiment: Negative
Publish Date: 2024-09-04 18:15:30
Phreesia (PHR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.68 per share a year ago.
Sentiment: Positive
Publish Date: 2024-08-29 10:15:39
Get a deeper insight into the potential performance of Phreesia (PHR) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Sentiment: Negative
Publish Date: 2024-08-29 07:25:00
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
Sentiment: Negative
Publish Date: 2024-08-28 07:25:00
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
Sentiment: Negative
Publish Date: 2024-08-27 07:25:00
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
Sentiment: Negative
Publish Date: 2024-08-26 07:30:00
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
Sentiment: Negative
Publish Date: 2024-08-23 07:30:00
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
Sentiment: Negative
Publish Date: 2024-08-22 07:30:00
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
Sentiment: Negative
Publish Date: 2024-08-21 07:25:00
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
